Indications and contraindications for pore laser treatment: treatment targets and precautions

Pore laser treatment is one of the representative non-invasive dermatological treatments that reduce enlarged pores and improve skin texture. However, not all patients can achieve the same results, and treatment targets may be determined or limited depending on specific skin conditions or health status. This article systematically explains the indications (who can receive it), contraindications (who should avoid it), and key factors considered in the actual clinical decision-making process.

To determine appropriate candidates for pore laser treatment, it is necessary to comprehensively assess various clinical criteria such as skin health status, ongoing treatments, photosensitivity, and infection risk, not just superficial symptoms. By examining your own situation based on accurate information, you can prevent unnecessary treatments or risky procedures in advance.

Indications for Pore Laser Treatment: Criteria for Determining Treatment Targets

Indications for pore laser treatment refer to the conditions and states of patients to whom this treatment can be safely and effectively applied. According to dermatological literature, pore-reducing laser treatment has the following key indications.

1. Enlarged pores associated with sebum secretion

One of the most common causes of enlarged pores is increased sebum secretion. When excessive sebum around the T-zone (forehead, nose, chin) expands the pores, laser treatment can suppress the activity of the sebaceous glands and regenerate the collagen around the pores to reduce their size. Clinical effects have been reported, especially in patients with moderate to severe oily skin. In these cases, treatment effects are generally good, and complex laser protocols (e.g., fractional CO₂ or long-pulse Nd:YAG) may be used.

2. Age-related pore laxity and loss of elasticity

As we age, the reduction of collagen and elastin in the skin leads to a decrease in the elasticity of the surrounding tissue, causing the pores to stretch. Clinical studies suggest that thermal stimulation using fractional lasers or non-fractional Nd:YAG lasers induces the reorganization of collagen in the dermis, restoring skin elasticity and reducing pore size. Patients over 30 with goals for pore improvement due to skin aging are good candidates.

3. Enlarged pores after acne or inflammation

When pores are enlarged and the skin texture is rough due to acne dermatitis or recurring inflammation, it also falls under the indications. In these cases, laser treatment can assist not only in pore reduction but also in improving acne scars and inflammation. Clinical guidelines recommend treatment after the inflammation has sufficiently subsided (usually after more than 2 weeks) and the skin has stabilized.

4. Pore enlargement related to photodamage (UV damage)

Long-term exposure to ultraviolet light leads to photodamage that results in collagen degeneration in the dermis and enlarges the pore openings. In this case, pore laser treatment can regenerate the damaged collagen and normalize the thickness of the epidermis to achieve pore reduction effects. This indication is particularly clear in patients who engage in outdoor activities or do not adequately use sunscreen.

Contraindications: Cases Where Pore Laser Treatment Should Be Avoided

Contraindications refer to medical conditions where treatment should not be performed due to risks. Contraindications for pore laser treatment are divided into absolute contraindications and relative contraindications, each with varying degrees of severity and clinical judgment.

Absolute Contraindications: Cases Where Treatment Should Not Be Proceeded With

1) Active infections or open lesions:In cases of herpes virus infection (cold sore), vesicles, or bacterial infections present at the treatment site, laser heat can activate the virus or spread the infection. Antiviral medications should be administered at least 7-10 days prior to treatment. Areas with open wounds or skin abrasions should also be avoided for treatment. For patients with skin laxity or a tendency to bleed, prior evaluation through consent and blood tests is essential.

2) Patients on specific medications:Patients taking photosensitizing medications, such as the acne treatment isotretinoin (Accutane), may experience extreme skin sensitivity, significantly increasing the risk of burns. Treatment is recommended at least 6 months after stopping isotretinoin. Additionally, some tetracycline antibiotics (e.g., minocycline, doxycycline) may also increase photosensitivity, so treatment should be conducted after stopping those medications.

3) Keloid predisposition or tendency for excessive scar formation:Keloids are conditions in which collagen excessively proliferates after trauma, and laser thermal stimulation can paradoxically worsen keloids. Patients who have formed keloids after past surgeries or trauma should avoid laser treatments that cause dermal damage. In these cases, lasers that minimize epidermal damage or alternative treatment methods should be considered.

4) During pregnancy or breastfeeding:Due to hormonal changes during pregnancy, the production of melanin increases, leading to a higher risk of photodamage. Additionally, since the safety for the fetus has not been completely proven, avoiding treatment during pregnancy is the clinical standard. Even during breastfeeding, treatment is postponed from a conservative perspective.

Relative contraindication: Conditional treatment may be possible after careful evaluation.

1) Progressive skin diseases (e.g., lupus, vasculitis):Patients with autoimmune diseases or vasculitis may have abnormal skin responses to laser stimulation. Careful treatment can only proceed when the disease is sufficiently controlled through collaboration between a dermatologist and a rheumatologist. The status of immunomodulatory medications such as steroids should be checked and adjusted before and after treatment.

2) Very dark skin tones (Fitzpatrick V~VI):If the skin is very dark, there is a high risk of hyperpigmentation (post-inflammatory hyperpigmentation, PIH) or hypopigmentation. Treatment should proceed using long-wavelength, heat-absorbing lasers (e.g., Nd:YAG 1064nm) and with low energy and multiple sessions. It is not an absolute ban, but careful protocol adjustment is essential.

3) Chemical peels or other laser treatments within the last 3 months:Applying additional thermal stimulation on unhealed skin increases the risk of excessive inflammatory responses, burns, and scarring. Typically, intervals of at least 4 weeks after previous treatments and more than 3 months after deep peels are recommended.

4) Active acne or inflammatory dermatitis:Laser heat during an active inflammatory state can aggravate inflammation or trigger bacterial proliferation. Treatments must be conducted in a state where inflammation is minimized. Depending on clinical judgment, inflammation may be controlled first with antibiotic or anti-inflammatory treatments before planning pore laser procedures.

Assessment of adaptability by skin type

The effectiveness and safety of pore laser treatments are closely related to an individual's skin type (Fitzpatrick Scale). According to dermatological research, the recommended laser wavelength, energy settings, and treatment intervals vary depending on skin type.

Skin types I~III (light skin): Optimal indications

Patients with light skin tones are the best candidates for pore laser treatment. They have lower melanin content, reducing the risk of pigmentation, and most laser wavelengths (e.g., fractional CO₂ 2940nm, fractional Erbium 2940nm, Nd:YAG) can be safely used. Clinical studies have reported a 20–40% improvement in pore reduction and increased skin elasticity in this group. Therefore, side effects can be minimized after treatment, potentially shortening the treatment schedule.

Skin type IV (medium-dark skin): Cautionary approach

This group may belong to relative contraindications and treatment is possible but requires careful protocol adjustments. For wavelength choice, long-wavelength lasers such as Nd:YAG (1064nm) are preferred, and energy (fluence) should start at a low range and be gradually increased. Clinical guidelines recommend multiple treatments spaced at least 4 weeks apart. Strong UV protection for more than 6 months after treatment is essential to prevent hyperpigmentation.

Skin types V~VI (very dark skin): Limited indications

In this group, the risk of hyperpigmentation and hypopigmentation is very high. Short-wavelength lasers like fractional CO₂ should be avoided, and Nd:YAG (1064nm) or specially designed long-wavelength lasers should be chosen. Energy should start at 50–70% of the usual settings, and treatment intervals should be extended to 6–8 weeks. Reaction should be verified through a test patch beforehand, and patients should be thoroughly informed about the risk of pigmentation. Patients in this group may be safer reviewing other laser alternative methods (e.g., radiofrequency, ultrasound).

Considerations for indications by age

The underlying causes of pore issues and responses to treatment vary by age group, making age an important variable in indication assessment.

Teens to 20s: Pore issues centered on sebum secretion

During adolescence and early adulthood, hormonal influences lead to active sebum secretion, tending to enlarge pores. The main cause of pore problems at this stage is the increase in sebaceous gland size, so pore reduction lasers are effective. However, as the skin is not yet sufficiently mature, it is advisable to lower the energy and choose a gentle protocol. Long-term skincare education (sunscreen, sebum management) should also be provided to prevent recurrence.

30s to 40s: Mixed pore issues

In this age group, sebum secretion decreases, but pore loosening due to reduced skin elasticity becomes a major concern. Age-related collagen loss leads to loosening of the surrounding tissue of the pores. Therefore, treatment should be designed with the goal of collagen reconstruction through thermal stimulation rather than simple inhibition of sebaceous glands. Fractional lasers or non-fractional Nd:YAG may be good choices, with clinically effective results seen with 3–4 sessions at intervals of 2–3 weeks.

Age 50 and above: Advanced aging and photodamage

In this age group, severe photodamage, photoaging, and significant collagen loss work in combination. The goal extends beyond simple pore issues to overall improvement of skin texture. Deep-energy fractional CO₂ lasers or combination treatments (laser + microdermabrasion + energy-based device combinations) may be considered. However, as skin recovery ability is diminished, sufficient recovery periods and follow-ups are essential.

Evaluation of accompanying diseases and medications

A comprehensive medical evaluation before pore laser treatment should include the patient's overall health status, treatment of ongoing diseases, and a list of medications being taken. Certain diseases and medications may serve as contraindications or determine conditional progression.

Diabetes or immunosuppressive condition

Patients with diabetes, especially those with poor blood sugar control, have decreased wound healing abilities. Clinical studies indicate that pore laser treatments are possible for well-controlled diabetic patients (HbA1c < 7.5%), but strict infection prevention and wound management are necessary after treatment. Patients taking immunosuppressants (e.g., long-term corticosteroids, biological agents) also have increased risk of infection and delayed wound healing, so prior consultation with a physician is essential.

Use of anticoagulants or antiplatelet agents

Patients taking anticoagulants such as warfarin, aspirin, or clopidogrel (Plavix) have a higher risk of bleeding after treatment. Generally, it is necessary to check with the prescribing physician whether these medications can be stopped 3–5 days prior to treatment. If medications cannot be discontinued due to life-threatening cardiovascular diseases, low-energy lasers or non-invasive alternative treatments should be considered.

Long-term steroid use

Patients taking steroids long-term (e.g., for autoimmune diseases, chronic inflammatory diseases) have decreased skin recovery abilities and immune responses. The risk of infection, inflammation, and scarring post-treatment increases, so it is essential to review the possibility of adjusting steroid dosage in consultation with the attending physician and to proceed cautiously.

Final confirmation of indications before treatment and consultation process

The evaluation of indications and contraindications for pore laser treatment is not a one-time process but a systematic process involving consultation, examination, testing, and final consent decision. Responsible clinical practice includes the following steps.

Detailed medical history taking and skin examination

During the initial consultation, specific records of the onset of pore issues, aggravating factors (UV exposure, cosmetics, lifestyle habits), previous treatment experiences, drug allergies, current medications, and systemic disease history should be made. Visual skin examinations assess pore size, distribution, and accompanying symptoms (acne, pigmentation, wrinkles, etc.). Tools like dermatoscopy may be used to objectively measure the depth and shape of the pores.

Screening for photosensitivity and infection risk

Specifically confirm the patient's history of past herpes simplex virus recurrence, keloid family history, and skin reaction hypersensitivity. Consider herpes virus antibody testing and blood coagulation profile testing if necessary. Check for the presence of current active skin infections, open wounds, or inflammatory skin diseases, and if present, decide to postpone the treatment.

Review the medication list and consult with medical staff.

Organize a list of all oral medications, topical medications, and supplements the patient is taking. Specifically check for the absence of isotretinoin, antibiotics, immunosuppressants, or anticoagulants. If the prescribed medication is a photosensitizer or poses a risk of hindering wound healing, first consult with the prescribing physician to review the possibility of discontinuation or adjustment. If the patient has underlying conditions such as diabetes, cardiovascular diseases, or autoimmune diseases, assess the treatment safety together with the relevant specialists.

Set expectations and prepare a consent form.

Clearly explain that the effectiveness of pore laser treatment can vary greatly among individuals. Emphasize that pore size generally reduces by 15-30%, and achieving complete disappearance (100%) is unlikely. Also, detail the risks of side effects (temporary redness, swelling, and rarely burns, pigmentation). After this process, prepare the final consent form and obtain the patient's signature to clarify legal and ethical responsibilities.

Medical Disclaimer: Medical Law Article 56 Notice:This text was written to provide dermatological information about the indications and contraindications of pore laser treatment and does not replace individual diagnosis or treatment prescriptions. The effectiveness, safety, and appropriate timing for pore laser treatment can vary significantly depending on individual skin type, health status, medication use, and past medical history. Always consult directly with a dermatologist to establish a treatment plan that is suitable for you.